CL2012000883A1 - Compounds derived from (hetero, aryl) -pyrazole, modulators of calcium channels; pharmaceutical composition comprising them; and its use in the treatment of cancer, autoimmune, allergic, inflammatory diseases, among others. - Google Patents

Compounds derived from (hetero, aryl) -pyrazole, modulators of calcium channels; pharmaceutical composition comprising them; and its use in the treatment of cancer, autoimmune, allergic, inflammatory diseases, among others.

Info

Publication number
CL2012000883A1
CL2012000883A1 CL2012000883A CL2012000883A CL2012000883A1 CL 2012000883 A1 CL2012000883 A1 CL 2012000883A1 CL 2012000883 A CL2012000883 A CL 2012000883A CL 2012000883 A CL2012000883 A CL 2012000883A CL 2012000883 A1 CL2012000883 A1 CL 2012000883A1
Authority
CL
Chile
Prior art keywords
pyrazole
modulators
treatment
pharmaceutical composition
autoimmune
Prior art date
Application number
CL2012000883A
Other languages
Spanish (es)
Inventor
Peyyappan Muthuppalaniappan
Srikant Viswanadha
Gayatri Swaroop Vakkalanka Swaroop Kumas V S Merikapudi
Original Assignee
Rhizen Pharmaceuticals S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=69650498&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2012000883(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhizen Pharmaceuticals S A filed Critical Rhizen Pharmaceuticals S A
Publication of CL2012000883A1 publication Critical patent/CL2012000883A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compuestos derivados de heteroaril-pirazol, moduladores de los canales de calcio; composición farmacéutica; y su uso para preparar un medicamento útil en el tratamiento de un trastorno autoinmune, como artritis, psoriasis, colitis ulcerativa, asma, entre otrasCompounds derived from heteroaryl-pyrazole, modulators of calcium channels; pharmaceutical composition; and its use to prepare a drug useful in the treatment of an autoimmune disorder, such as arthritis, psoriasis, ulcerative colitis, asthma, among others.

CL2012000883A 2009-10-08 2012-04-05 Compounds derived from (hetero, aryl) -pyrazole, modulators of calcium channels; pharmaceutical composition comprising them; and its use in the treatment of cancer, autoimmune, allergic, inflammatory diseases, among others. CL2012000883A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN2439CH2009 2009-10-08
IN2636CH2009 2009-10-30
US26554009P 2009-12-01 2009-12-01
IN158CH2010 2010-01-25
IN1513CH2010 2010-06-02

Publications (1)

Publication Number Publication Date
CL2012000883A1 true CL2012000883A1 (en) 2012-11-30

Family

ID=69650498

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012000883A CL2012000883A1 (en) 2009-10-08 2012-04-05 Compounds derived from (hetero, aryl) -pyrazole, modulators of calcium channels; pharmaceutical composition comprising them; and its use in the treatment of cancer, autoimmune, allergic, inflammatory diseases, among others.

Country Status (1)

Country Link
CL (1) CL2012000883A1 (en)

Similar Documents

Publication Publication Date Title
DOP2018000257A (en) PIRIDINES REPLACED WITH HETEROARILO AND METHODS OF USE
CL2014003388A1 (en) Triazolone-derived compounds, such as mpges-1 inhibitors; process of preparing said compounds; pharmaceutical composition that includes them, useful for the treatment of inflammation, asthma, epoc, arthritis, parkinson's disease and autoimmune diseases, among other diseases.
CL2010001637A1 (en) Compounds derived from isoindolones; pharmaceutical composition comprising them; and its use as mek kinase inhibitors to treat hyperproliferative and / or inflammatory diseases such as cancer, rheumatoid arthritis among others.
CO7240375A2 (en) Substituted tricyclic compounds as fgfr inhibitors
CL2013002898A1 (en) Compounds derived from aryl or heteroaryl substituted benzene; pharmaceutical composition that understands them and use in the treatment of cancer.
UY35467A (en) ORGANIC COMPOUNDS
CR20140405A (en) QUINASA INHIBITOR REGULATOR SIGNAL APOPTOSIS
ECSP14013284A (en) BENZILINDAZOLS REPLACED FOR USE AS INHIBITORS OF QUINASA BUB1 IN THE TREATMENT OF HYPERPROLIFERATIVE DISEASES
GT201400147A (en) PYRIMIDINES AND FUSIONATED TRIAZINS REPLACED AND ITS USE
CO6721019A2 (en) Quinazolincarboxamide azetidines
CR20160272A (en) Nrf2 REGULATORS
HN2010002478A (en) INDAZOL DERIVATIVES REPLACED WITH PHENYL AND BENZODIOXINYL
CU20140048A7 (en) NEW PURINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND NEURODEGENERATIVE DISORDERS
GT201500138A (en) NOVEDOSOUS DERIVATIVES OF BENCIMIDAZOL AS ANTAGONISTS OF EP4
NI201300041A (en) SPIRO-OXINDOL MDM2 ANTAGONISTS
UY33735A (en) ANTIVIRAL COMPOUNDS
MX2013000567A (en) PHARMACEUTICAL COMPOSITIONS OF C-MET MODULATORS.
DOP2015000270A (en) POTENTIAL OF INHIBITORS OF THE HOMOLOGIST OF ZESTE
CR20110309A (en) ORGANIC COMPOUNDS
ECSP11011184A (en) ORGANIC COMPOUNDS
CR20210079A (en) SULFAMOILARYLAMIDES AND THEIR USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B
UY33883A (en) NEW HETEROCYCLIC DERIVATIVES
AR091837A1 (en) COMPOUNDS FOR DIRECTED IMMUNOTHERAPY
ECSP13012519A (en) BENZAMIDA SUBSTITUTED COMPOUNDS
DOP2012000250A (en) COMPOUNDS OF THE Faith COMPLEX (III) FOR THE TREATMENT AND PROFILAXIS OF IRON DEFICIENCY SYMPTOMS AND IRON DEFICIENCY ANEMIES